Ana Martinez
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
From Diarylsulfides to Diarylamines: New Ebola Virus Entry Inhibitors with Improved Metabolic Stability.
Journal: Journal of medicinal chemistry
Published: May 17, 2025
Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood-Brain Barrier-Permeable Ebola Virus Entry Inhibitors.
Journal: Journal of medicinal chemistry
Published: September 09, 2024
Phase IIa randomized placebocontrolled clinical trial to evaluate the efficacy of bromhexine in combination with standard therapy in the early treatment of COVID-19 in primary care patients.
Journal: Revista medica de Chile
Published: August 23, 2024
Designing multitarget ligands for neurodegenerative diseases with improved permeability trough PLGA nanoencapsulation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 05, 2024
A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care.
Journal: Annals of medicine
Published: October 17, 2023
N'-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile.
Journal: Journal of medicinal chemistry
Published: April 06, 2023
Efficacy of Bromhexine versus Standard of Care in Reducing Viral Load in Patients with Mild-to-Moderate COVID-19 Disease Attended in Primary Care: A Randomized Open-Label Trial.
Journal: Journal of clinical medicine
Published: November 24, 2022
Seroprevalence of SARS-CoV-2 in a Fully Operative Dentistry Academic Center in Madrid (Spain) During the De-escalation Phase of the COVID-19 Pandemic. Are Our Dentists at Greater Risk?
Journal: Oral health & preventive dentistry
Published: October 19, 2022
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19.
Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19.
Journal: Frontiers in pharmacology
Published: May 24, 2022
Targeting autophagy in disease: established and new strategies.
Journal: Autophagy
Published: July 09, 2021
Kinase Inhibitors as Underexplored Antiviral Agents.
Journal: Journal of medicinal chemistry
Published: May 10, 2021
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 09, 2021
Last Updated: 09/26/2026